Stevanato Group S.p.A. (NYSE:STVN) Receives Average Recommendation of “Buy” from Analysts

Posted by Brian Himes on Jul 23rd, 2026

Shares of Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) have earned an average recommendation of “Buy” from the six ratings firms that are presently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and two have assigned a strong buy rating to the company.

Several research analysts have recently issued reports on STVN shares. Wolfe Research began coverage on Stevanato Group in a research note on Tuesday, June 2nd. They issued an “outperform” rating and a $21.00 price objective for the company. Weiss Ratings upgraded Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 16th. Finally, TD Cowen upgraded shares of Stevanato Group to a “strong-buy” rating in a report on Wednesday, June 17th.

Read Our Latest Report on Stevanato Group

Insider Buying and Selling at Stevanato Group

In other Stevanato Group news, Director Donald E. Morel, Jr. sold 1,493 shares of the company’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of €17.09, for a total value of €25,515.37. Following the sale, the director directly owned 37,424 shares of the company’s stock, valued at approximately €639,576.16. This represents a 3.84% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director William J. Federici sold 1,493 shares of the stock in a transaction dated Monday, June 15th. The stock was sold at an average price of €17.09, for a total value of €25,515.37. Following the sale, the director directly owned 26,991 shares in the company, valued at €461,276.19. This represents a 5.24% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 5,972 shares of company stock worth $102,061 over the last ninety days. 0.70% of the stock is owned by insiders.

Institutional Trading of Stevanato Group

A number of hedge funds have recently modified their holdings of STVN. Cooper Investors PTY Ltd. boosted its holdings in Stevanato Group by 17.8% during the fourth quarter. Cooper Investors PTY Ltd. now owns 695,245 shares of the company’s stock worth $13,988,000 after buying an additional 104,937 shares in the last quarter. Conestoga Capital Advisors LLC increased its holdings in Stevanato Group by 7.6% in the first quarter. Conestoga Capital Advisors LLC now owns 8,491,751 shares of the company’s stock valued at $116,762,000 after buying an additional 602,050 shares in the last quarter. Jennison Associates LLC raised its position in shares of Stevanato Group by 13.7% in the fourth quarter. Jennison Associates LLC now owns 1,772,896 shares of the company’s stock worth $35,671,000 after acquiring an additional 213,602 shares during the period. Kornitzer Capital Management Inc. KS purchased a new stake in shares of Stevanato Group during the 1st quarter worth about $1,856,000. Finally, Van Berkom & Associates Inc. boosted its stake in shares of Stevanato Group by 2,944.2% during the 1st quarter. Van Berkom & Associates Inc. now owns 170,994 shares of the company’s stock worth $2,351,000 after acquiring an additional 165,377 shares in the last quarter.

Stevanato Group Price Performance

Shares of STVN opened at €19.43 on Friday. The firm has a market capitalization of $5.88 billion, a PE ratio of 32.93, a price-to-earnings-growth ratio of 1.76 and a beta of 0.78. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.63 and a quick ratio of 1.11. Stevanato Group has a 1-year low of €12.89 and a 1-year high of €28.00. The company’s fifty day moving average price is €18.31 and its 200-day moving average price is €17.03.

Stevanato Group (NYSE:STVN – Get Free Report) last released its earnings results on Friday, May 8th. The company reported €0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of €0.12 by (€0.01). Stevanato Group had a net margin of 11.76% and a return on equity of 10.27%. The firm had revenue of €273.57 million during the quarter. During the same quarter last year, the firm posted $0.10 earnings per share. Stevanato Group’s revenue for the quarter was up 6.6% compared to the same quarter last year. On average, equities research analysts predict that Stevanato Group will post 0.68 EPS for the current year.

About Stevanato Group

(Get Free Report)

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.